Core Insights - The article promotes iREIT on Alpha as a platform providing in-depth research on various income alternatives including REITs, mREITs, Preferreds, BDCs, MLPs, and ETFs, highlighting its positive testimonials [1] Group 1 - iREIT on Alpha offers a free 2-week trial for users to explore its research services [1] - The platform has received 438 testimonials, with most rated 5 stars, indicating high user satisfaction [1]

Core Viewpoint - UnitedHealth Group Inc. reported mixed first-quarter 2025 results, with adjusted EPS of $7.20 falling short of estimates, while revenues increased year over year but missed consensus expectations due to lower premiums [1][2]. Financial Performance - Adjusted EPS for Q1 2025 was $7.20, missing the Zacks Consensus Estimate of $7.27, but reflecting a 4.2% year-over-year increase [1]. - Revenues rose 9.8% year over year to $109.58 billion, but missed the consensus mark by 1.4% [1]. - Medical care ratio (MCR) was 84.8%, worsening from 84.3% a year ago and below the consensus estimate of 85.9% [4]. - Total operating costs increased 9.4% year over year to $100.5 billion, exceeding model estimates [5]. - Operating earnings grew 15% year over year to $9.1 billion, with net margin improving from negative 1.4% to 5.7% [6]. Business Segment Performance - UnitedHealthcare revenues increased 12.3% year over year to $84.6 billion, driven by domestic commercial membership growth, surpassing estimates [7]. - Optum revenues were $63.9 billion, up 4.6% year over year, but fell short of the consensus mark [8]. - UnitedHealthcare served 50.1 million members, a 1.9% year-over-year growth, but below the consensus estimate of 50.6 million [9]. Financial Position - Cash and short-term investments rose to $34.3 billion from $29.1 billion at the end of 2024 [10]. - Total assets increased to $309.8 billion from $298.3 billion at the end of 2024 [11]. - Long-term debt decreased to $71.29 billion from $72.36 billion [11]. - Operating cash flows surged to $5.5 billion from $1.1 billion year over year [12]. Capital Deployment - UnitedHealth returned over $5 billion to shareholders through share repurchases and dividends in Q1 2025 [13]. 2025 Outlook - Management revised adjusted net EPS guidance to between $26 and $26.50, down from previous estimates [14]. - Projected net earnings for 2025 are expected to be between $22.5 billion and $23.1 billion, an increase from 2024 [14]. - Revenue estimates for 2025 are between $450 billion and $455 billion, up from $400.3 billion in 2024 [14].

Market Overview - Wall Street experienced a rebound in risk appetite ahead of the Easter weekend, driven by positive signals from President Trump regarding trade negotiations with the EU and China [1] - The S&P 500 rose by 0.9%, while the Nasdaq 100 increased by 0.5%, recovering from a previous 3% decline [2] - The Dow Jones fell by 0.9%, primarily due to a significant 23% drop in UnitedHealth Group Inc. after the company reduced its full-year earnings forecast [2] Sector Performance - Energy stocks led the gains for the day, supported by rising oil prices, with Exxon Mobil Corp. increasing by 4.1% and Chevron Corp. advancing by 3.5% [2] - The SPDR S&P 500 ETF Trust rose by 0.8% to $530.09, while the SPDR Dow Jones Industrial Average fell by 0.7% to $394.05 [7] - The Energy Select Sector SPDR Fund outperformed with a 3.5% increase, while the Health Care Select Sector SPDR Fund lagged, down 0.1% [7] Notable Stock Movements - Eli Lilly Inc. surged by 16% after announcing successful Phase 3 trials for its oral GLP-1 receptor agonist, Orforglipron [7] - Fidelity National Information Services jumped by 9% following a $13.5 billion acquisition of Global Payments Inc.'s Issuer Solutions business, expected to generate over $125 million in annual revenue synergies [7] - Companies reacting to earnings reports included American Express Co. up 0.5%, Blackstone Inc. up 1.9%, and Charles Schwab Corp. up 2.7% [7] - Netflix Inc. rose by 2% ahead of its earnings report scheduled for release after market close [7]

Group 1 - The Pragmatic Investor focuses on global macro, international equities, commodities, tech, and cryptocurrencies, aiming to guide investors of all levels [1] - The platform offers features such as a portfolio, weekly market updates, actionable trades, technical analysis, and a chat room for investor engagement [1] - James Foord, an economist with a decade of experience in global market analysis, leads The Pragmatic Investor, emphasizing the creation of diversified portfolios to preserve and increase wealth [1]

Financial Data and Key Metrics Changes - The company revised its adjusted earnings per share outlook for 2025 to $26 to $26.50, reflecting performance challenges primarily in its Medicare businesses [7][29] - The consolidated revenue outlook remains at $450 billion to $455 billion, with expectations for UnitedHealthcare and Optum Rx revenues to exceed initial views, offsetting a reduced outlook for Optum Health [30][31] - The full year medical care ratio is now expected to be 87.5% plus or minus 50 basis points, indicating higher utilization across senior populations [31] Business Line Data and Key Metrics Changes - UnitedHealthcare's Medicare Advantage business is projected to serve an additional 800,000 people in 2025, while Optum Health aims to add 650,000 net new patients to value-based care arrangements [16][43] - Optum Rx revenues grew by 14%, exceeding $35 billion for the quarter, with script growth of 3% driven by customer retention and new customer wins [44] Market Data and Key Metrics Changes - The company noted a significant increase in care activity in its Medicare Advantage business, with first quarter indications suggesting care activity increased at twice the rate anticipated [10][29] - The company experienced a sharp increase in elective care activity, particularly in the group Medicare Advantage segment, attributed to higher member premiums driven by Medicare funding cuts [36][66] Company Strategy and Development Direction - The company is focusing on improving engagement with complex patients and enhancing clinical workflows to transition effectively to the new CMS risk model [15][39] - The company continues to innovate in its service offerings, such as the HouseCalls program, which provides in-home clinical visits to seniors [21][22] - The company emphasizes the importance of transparency and affordability in healthcare, aiming to reduce costs for consumers while maintaining high-quality care [28][132] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment with current performance but remains committed to improving results throughout 2025 and into 2026, targeting long-term earnings per share growth of 13% to 16% [46][47] - The management acknowledged the challenges posed by recent Medicare funding cuts and the need to better anticipate and address second-order effects in the market [90][96] Other Important Information - The company is actively engaging with state customers to address Medicaid funding issues and is optimistic about recent rate adjustments aligning more closely with member acuity [41][130] - The company is concerned about legislative changes affecting pharmacy benefit managers (PBMs) and their potential impact on patient access to medications [126][127] Q&A Session Summary Question: Medicare Advantage cost trend expectations - Management indicated that care levels were anticipated to be consistent with 2024 but have seen a significant increase in the first quarter, particularly in physician and outpatient services [49][55] Question: Connection between primary care visits and Optum Health performance - Management clarified that while primary care visits have increased, the challenges in Optum Health are due to the profile of new value-based patients and the impact of the V28 phase [58][68] Question: Impact of elevated care on group Medicare Advantage - Management confirmed that the elevated care activity is primarily observed in community and group Medicare Advantage, influenced by premium increases [98][102] Question: Long-term growth rate recovery - Management expressed confidence in returning to long-term growth rates, supported by improved 2026 rates and ongoing engagement with state partners [106][110] Question: Medicare Advantage margins and timeline for recovery - Management stated that margins for Medicare Advantage are still within targeted ranges for 2025, with expectations to return to historical planning targets in 2026 [114][118] Question: Policy implications of PBM reform and Medicaid funding - Management highlighted their leadership in transparency and affordability in the PBM space and emphasized the importance of maintaining access to medications for patients [122][130]

Wall Street plunged on Thursday on the final trading day of the week, with focus on US-Japan tariff talks, while a slump in UnitedHealth’s shares following a forecast cut by the insurer weighed on the Dow.In morning trading, the Dow Jones Industrial Average slid 637 points, or 1.6%, to 39,032. The S&P 500 fell 0.1%, and the Nasdaq was down 0.5%. 3 The Dow tumbled more than 600 points, or 1.6% on Thursday. Getty ImagesAhead of the long weekend, all three major Wall Street indexes are on track for weekly lo ...

Core Viewpoint - UnitedHealth's stock experienced a significant decline of 19.17% in the first hour of trading following its latest earnings report, which underperformed analyst expectations for both revenue and earnings per share (EPS) [1][3][4]. Financial Performance - UnitedHealth reported revenue of $109.58 billion, missing the expected $111.60 billion, and an EPS of $7.20, below the anticipated $7.29 [3]. - The company significantly lowered its EPS guidance for 2025, now expecting it to be between $26 and $26.50, down from a previous range of $29.50 to $30 [4]. Market Impact - The sharp decline in UnitedHealth's stock negatively affected the broader healthcare sector, with other companies experiencing significant drops in their stock prices [8]. - Humana saw a decline of 8.97% to $260.76, while Cigna Group remained relatively stable with a minor decrease of 0.07% [9]. Investor Sentiment - The scale of UnitedHealth's stock drop reflects low confidence among traders regarding the sustainability of high valuations in major U.S. companies, amidst concerns about consumer confidence and potential recession [7].

Core Insights - UnitedHealth Group reported revenue of $109.58 billion for the quarter ended March 2025, reflecting a year-over-year increase of 9.8% [1] - The earnings per share (EPS) for the quarter was $7.20, up from $6.91 in the same quarter last year, but below the consensus estimate of $7.27, resulting in an EPS surprise of -0.96% [1] Financial Performance - The reported revenue was 1.40% below the Zacks Consensus Estimate of $111.13 billion [1] - The Medical Care Ratio was reported at 84.8%, better than the estimated 85.9% [4] - Total revenues from UnitedHealthcare reached $84.62 billion, exceeding the average estimate of $83.20 billion, with a year-over-year change of +12.3% [4] Customer Metrics - The number of risk-based customers served by UnitedHealthcare was 8.41 million, lower than the average estimate of 9 million [4] - Fee-based customers served totaled 21.59 million, slightly above the average estimate of 21.46 million [4] - Total community and senior customers served was 20.13 million, close to the average estimate of 20.16 million [4] Revenue Breakdown - Investment and other income was reported at $1.03 billion, slightly below the average estimate of $1.06 billion, with a year-over-year change of +2.2% [4] - Product revenues were $13.04 billion, compared to the average estimate of $13.33 billion, reflecting a year-over-year increase of +9.5% [4] - Service revenues were $8.97 billion, below the average estimate of $9.76 billion, with a year-over-year change of +1% [4] - Premium revenues reached $86.53 billion, slightly below the average estimate of $86.94 billion, with a year-over-year increase of +11% [4] - Optum Insight revenues were $4.63 billion, below the average estimate of $5.11 billion, with a year-over-year change of +2.8% [4] - Optum Rx revenues were $35.13 billion, exceeding the average estimate of $34.11 billion, with a year-over-year increase of +13.9% [4] - Optum Health revenues were reported at $25.31 billion, significantly below the average estimate of $28.97 billion, reflecting a year-over-year decrease of -5.3% [4] Stock Performance - UnitedHealth shares have returned +16.3% over the past month, outperforming the Zacks S&P 500 composite, which declined by -6.3% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

UnitedHealth shares plunged 17.4% premarket on Thursday after the insurer dramatically slashed its profit forecast for the year after it revealed disappointing earnings.The healthcare company – whose top insurance executive was shot dead in midtown Manhattan in December – cut its full-year adjusted earnings outlook to a range of $26 to $26.50 per share, down from $29.50 to $30 a share.The firm also reported adjusted income of $7.20 a share in the first quarter, below analysts’ expectations of $7.29, accordi ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...